Home/Filings/4/0000950170-25-005353
4//SEC Filing

Pfeil Keith W 4

Accession 0000950170-25-005353

CIK 0001237831other

Filed

Jan 13, 7:00 PM ET

Accepted

Jan 14, 4:12 PM ET

Size

14.2 KB

Accession

0000950170-25-005353

Insider Transaction Report

Form 4
Period: 2025-01-10
Pfeil Keith W
DirectorPresident, CEO
Transactions
  • Exercise/Conversion

    Stock Option (Right to Buy Class A Common Stock)

    2025-01-108,334833 total
    Exercise: $53.27Exp: 2030-01-22Class A Common Stock (8,334 underlying)
  • Exercise/Conversion

    Class A Common Stock

    2025-01-10$49.65/sh+5,833$289,6085,833 total
  • Exercise/Conversion

    Stock Option (Right to Buy Class A Common Stock)

    2025-01-105,8330 total
    Exercise: $49.65Exp: 2029-09-03Class A Common Stock (5,833 underlying)
  • Exercise/Conversion

    Class A Common Stock

    2025-01-10$53.27/sh+8,334$443,95214,167 total
  • Sale

    Class A Common Stock

    2025-01-10$88.17/sh12,501$1,102,2131,666 total
  • Sale

    Class A Common Stock

    2025-01-10$89.17/sh1,666$148,5570 total
Footnotes (5)
  • [F1]This sale was effected pursuant to a Rule 10b5-1 trading plan dated December 15, 2023 executed by the reporting person.
  • [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $87.60 to $88.55, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.
  • [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $88.69 to $89.63, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) to this Form 4.
  • [F4]These options were granted on September 3, 2019 and are fully vested.
  • [F5]These options were granted on January 22, 2020 and are fully vested.

Documents

1 file

Issuer

GLOBUS MEDICAL INC

CIK 0001237831

Entity typeother

Related Parties

1
  • filerCIK 0001752014

Filing Metadata

Form type
4
Filed
Jan 13, 7:00 PM ET
Accepted
Jan 14, 4:12 PM ET
Size
14.2 KB